These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8995964)

  • 1. Trimethoprim-sulfamethoxazole-induced vanishing bile duct syndrome.
    Yao F; Behling CA; Saab S; Li S; Hart M; Lyche KD
    Am J Gastroenterol; 1997 Jan; 92(1):167-9. PubMed ID: 8995964
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) after administration of clindamycin and trimethoprim-sulfamethoxazole.
    Altraif I; Lilly L; Wanless IR; Heathcote J
    Am J Gastroenterol; 1994 Aug; 89(8):1230-4. PubMed ID: 8053440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrahepatic cholestasis associated with co-trimoxazole.
    Oliver RM; Rickenbach MA; Thomas MR; Neville E
    Br J Clin Pract; 1987 Oct; 41(10):975-6. PubMed ID: 3509795
    [No Abstract]   [Full Text] [Related]  

  • 4. Vanishing bile duct syndrome arising in a patient with HIV infection sequentially treated with trimethoprim/sulfamethoxazole and dapsone.
    Kathi PR; Tama M; Ehrinpreis M; Mutchnick M; Westerhoff M; Mowers J; Fontana RJ
    Clin J Gastroenterol; 2020 Apr; 13(2):276-280. PubMed ID: 31317370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimethoprim-sulfamethoxazole-associated hepatotoxicity - part of a hypersensitivity syndrome.
    Mainra RR; Card SE
    Can J Clin Pharmacol; 2003; 10(4):175-8. PubMed ID: 14712321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moxifloxacin associated vanishing bile duct syndrome.
    Robinson W; Habr F; Manlolo J; Bhattacharya B
    J Clin Gastroenterol; 2010 Jan; 44(1):72-3. PubMed ID: 19581811
    [No Abstract]   [Full Text] [Related]  

  • 7. Vanishing bile duct syndrome in a child with toxic epidermal necrolysis: an interplay of unbalanced immune regulatory mechanisms.
    Karnsakul W; Arkachaisri T; Atisook K; Wisuthsarewong W; Sattawatthamrong Y; Aanpreung P
    Ann Hepatol; 2006; 5(2):116-9. PubMed ID: 16807519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of bile ducts in drug-induced vanishing bile duct syndrome due to zonisamide.
    Vuppalanchi R; Chalasani N; Saxena R
    Am J Surg Pathol; 2006 Dec; 30(12):1619-23. PubMed ID: 17122520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimethoprim sulfamethoxazole-induced sweet syndrome.
    Azfar RS; Cohn J; Schaffer A; Kim EJ
    Arch Dermatol; 2009 Feb; 145(2):215-6. PubMed ID: 19221284
    [No Abstract]   [Full Text] [Related]  

  • 10. Vanishing bile duct syndrome associated with azithromycin in a 62-year-old man.
    Juricic D; Hrstic I; Radic D; Skegro M; Coric M; Vucelic B; Francetic I
    Basic Clin Pharmacol Toxicol; 2010 Jan; 106(1):62-5. PubMed ID: 19906050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute vanishing bile duct syndrome after ibuprofen therapy in a child.
    Taghian M; Tran TA; Bresson-Hadni S; Menget A; Felix S; Jacquemin E
    J Pediatr; 2004 Aug; 145(2):273-6. PubMed ID: 15289784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimethoprim-sulfamethoxazole-induced life-threatening agranulocytosis.
    Andrès E; Noel E; Maloisel F
    Arch Intern Med; 2003 Sep; 163(16):1975-6; author reply 1976. PubMed ID: 12963573
    [No Abstract]   [Full Text] [Related]  

  • 13. Systemic sulfa-induced Sweet's syndrome.
    Margaretten ME; Ruben BS; Fye K
    Arthritis Rheum; 2008 Jul; 59(7):1044-6. PubMed ID: 18576306
    [No Abstract]   [Full Text] [Related]  

  • 14. Trimethoprim-sulfamethoxazole induced erythrodermic psoriasis.
    Esposito M; Saraceno R; Schipani C; Di Marcantonio D; Bianchi L; Chimenti S
    J Infect; 2008 Jul; 57(1):90-2. PubMed ID: 18499260
    [No Abstract]   [Full Text] [Related]  

  • 15. Trimethoprim-sulfamethoxazole-induced aseptic meningitis.
    Repplinger MD; Falk PM
    Am J Emerg Med; 2011 Feb; 29(2):242.e3-5. PubMed ID: 20825900
    [No Abstract]   [Full Text] [Related]  

  • 16. A first case of trimethoprim-sulfamethoxazole induced Sweet's syndrome in a child.
    Khaled A; Kharfi M; Fazaa B; Kourda M; Bouaziz A; Kastalli S; Kamoun MR
    Pediatr Dermatol; 2009; 26(6):744-6. PubMed ID: 20199454
    [No Abstract]   [Full Text] [Related]  

  • 17. Hydroxycut-related Vanishing Bile Duct Syndrome.
    Adike A; Smith ML; Chervenak A; Vargas HE
    Clin Gastroenterol Hepatol; 2017 Jan; 15(1):142-144. PubMed ID: 27151488
    [No Abstract]   [Full Text] [Related]  

  • 18. [Tremor produced by trimethoprim-sulfamethoxazole].
    de Arce Borda AM; Goenaga Sánchez MA
    Neurologia; 2000; 15(6):264-5. PubMed ID: 11002706
    [No Abstract]   [Full Text] [Related]  

  • 19. Vanishing bile duct syndrome temporally associated with ibuprofen use.
    Alam I; Ferrell LD; Bass NM
    Am J Gastroenterol; 1996 Aug; 91(8):1626-30. PubMed ID: 8759674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prolonged cholestasis following single dose of cotrimoxazole++].
    Ruiz-Irastorza G; Montejo M; Ituarte J; Aguirre C
    Rev Clin Esp; 1996 Dec; 196(12):879-80. PubMed ID: 9132870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.